Managing Director, Future of Aging, Milken Institute Health
Diane Ty is the managing director of the Milken Institute Future of Aging team, overseeing its work at the intersection of healthy longevity and financial security. She leads its Alliance to Improve Dementia Care and other multisector programmatic efforts that promote policy, practice, and systems change in a life course approach to aging.
SM
Soo Borson, MD
Professor (part-time) of Clinical Family Medicine, University of Southern California; Professor Emerita, University of Washington
Dr. Soo Borson is a Professor (part-time) of Clinical Family Medicine at the University of Southern California and Professor Emerita at the University of Washington.
KP
Katie Partrick, PhD
Science Communications Specialist and Writer
Katie Partrick, PhD, is a science communications specialist and writer.
The prevalence of mild cognitive impairment (MCI) and dementia is increasing as advancements in medicine, public health, and living standards extend human lifespans. Approximately 12–18 percent of Americans aged 60 and older have MCI, and nearly 7 million older adults (aged 65 and older) currently live with Alzheimer’s disease (AD). By 2060, dementia is expected to affect one in five older adults, significantly increasing the already substantial impact of dementia care, currently costing $360 billion annually, excluding the considerable contributions of unpaid caregivers.
In response to this rapidly advancing field, the Milken Institute Alliance to Improve Dementia Care (the “Alliance”) presents an updated report to discuss new insights to overcome persistent barriers, identify scalable solutions, showcase case studies, and highlight innovations to enhance the early detection of MCI and dementia. Developed with input from Alliance members, expert interviews, insights from a multisector roundtable, and extensive research, the report outlines five recommendations centered around two themes: (1) improving primary care capacity and workflows and (2) expanding detection efforts beyond primary care.
Recommendations include normalizing brain health discussions, standardizing and integrating assessment tools, creating reimbursement incentives for cognitive testing, training primary and specialty care providers, and leveraging community-based settings to broaden detection efforts. Together, these strategies aim to drive progress in early dementia detection across healthcare and community settings.
The Alliance to Improve Dementia Care, part of the Milken Institute’s Center for the Future of Aging, utilizes a multi-sector approach to develop recommendations to improve care for individuals living with dementia across all stages...
Sarah Lenz Lock, JD Senior Vice President, Policy & Brain Health and Executive Director, Global Council on Brain Health, AARP 1. You are a Steering Committee member of the Milken Institute Alliance to Improve Dementia Care. Describe the...
Q & A with David B. Reuben, MD Director, Multicampus Program in Geriatric Medicine and Gerontology, Chief, Division of Geriatrics, University of California, Los Angeles You are a member of the Milken Institute Alliance to Improve Dementia...
Despite scientific progress over the past 25 years, dementia remains one of the toughest health-care challenges. Alzheimer’s disease is the sixth-leading cause of death in the United States, and the number of deaths from all related...
September 25, 2024 (Washington, DC)—The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), today announced...
Paul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.
This report covers the challenges that the US health-care system is facing as it prepares to meet the growing demand for care among individuals living with Alzheimer’s disease and related dementias (ADRD). It suggests that implementing care...
Howard Fillit, MD Co-Founder and Chief Science Officer, Alzheimer’s Drug Discovery Foundation Howard Fillit, MD is a geriatrician, neuroscientist, and innovative philanthropy executive, who has led the Alzheimer's Drug Discovery Foundation...
Over the last two-plus years, the Milken Institute Center for the Future of Aging has explored the financial and care-delivery gaps in the long-term care market, specifically the barriers to affordable care for middle-income households and...
Q & A with Debra Cherry, PhD Executive Vice President, Alzheimer's Los Angeles You are a member of the Milken Institute Alliance to Improve Dementia Care. Describe the expertise that you bring to the Alliance and how the ideas explored...